182 related articles for article (PubMed ID: 20222671)
1. Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer.
Brahemi G; Kona FR; Fiasella A; Buac D; Soukupová J; Brancale A; Burger AM; Westwell AD
J Med Chem; 2010 Apr; 53(7):2757-65. PubMed ID: 20222671
[TBL] [Abstract][Full Text] [Related]
2. A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer.
Burger AM; Gao Y; Amemiya Y; Kahn HJ; Kitching R; Yang Y; Sun P; Narod SA; Hanna WM; Seth AK
Cancer Res; 2005 Nov; 65(22):10401-12. PubMed ID: 16288031
[TBL] [Abstract][Full Text] [Related]
3. Autoubiquitination of BCA2 RING E3 ligase regulates its own stability and affects cell migration.
Amemiya Y; Azmi P; Seth A
Mol Cancer Res; 2008 Sep; 6(9):1385-96. PubMed ID: 18819927
[TBL] [Abstract][Full Text] [Related]
4. Regulation of metformin response by breast cancer associated gene 2.
Buac D; Kona FR; Seth AK; Dou QP
Neoplasia; 2013 Dec; 15(12):1379-90. PubMed ID: 24403860
[TBL] [Abstract][Full Text] [Related]
5. RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation.
Wang Z; Nie Z; Chen W; Zhou Z; Kong Q; Seth AK; Liu R; Chen C
Neoplasia; 2013 Sep; 15(9):1028-35. PubMed ID: 24027428
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor.
Kona FR; Stark K; Bisoski L; Buac D; Cui Q; Dou QP
Breast Cancer Res Treat; 2012 Sep; 135(2):495-503. PubMed ID: 22850893
[TBL] [Abstract][Full Text] [Related]
7. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
[TBL] [Abstract][Full Text] [Related]
8. Effects of partner proteins on BCA2 RING ligase activity.
Bacopulos S; Amemiya Y; Yang W; Zubovits J; Burger A; Yaffe M; Seth AK
BMC Cancer; 2012 Feb; 12():63. PubMed ID: 22315970
[TBL] [Abstract][Full Text] [Related]
9. Autoubiquitination of feline E3 ubiquitin ligase BCA2.
Wang W; Qu M; Wang J; Zhang X; Zhang H; Wu J; Yu B; Wu H; Kong W; Yu X
Gene; 2018 Jan; 638():1-6. PubMed ID: 28964893
[TBL] [Abstract][Full Text] [Related]
10. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
[TBL] [Abstract][Full Text] [Related]
11. E3 ubiquitin ligase BCA2 promotes breast cancer stemness by up-regulation of SOX9 by LPS.
Zheng M; Liu W; Zhang R; Jiang D; Shi Y; Wu Y; Ge F; Chen C
Int J Biol Sci; 2024; 20(7):2686-2697. PubMed ID: 38725852
[TBL] [Abstract][Full Text] [Related]
12. A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells.
Wang F; Zhai S; Liu X; Li L; Wu S; Dou QP; Yan B
Cancer Lett; 2011 Jan; 300(1):87-95. PubMed ID: 21035945
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.
Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J
Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of cullin-RING E3 ubiquitin ligase 4 with antitumor potential.
Wu K; Huynh KQ; Lu I; Moustakim M; Miao H; Yu C; Haeusgen MJ; Hopkins BD; Huang L; Zheng N; Sanchez R; DeVita RJ; Pan ZQ
Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33602808
[TBL] [Abstract][Full Text] [Related]
15. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Walter G; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
[TBL] [Abstract][Full Text] [Related]
16. Disulfiram's Anticancer Activity: Evidence and Mechanisms.
Jiao Y; Hannafon BN; Ding WQ
Anticancer Agents Med Chem; 2016; 16(11):1378-1384. PubMed ID: 27141876
[TBL] [Abstract][Full Text] [Related]
17. Discovery of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity: synthesis and in vitro biological evaluation. Part 1.
Bozorov K; Ma HR; Zhao JY; Zhao HQ; Chen H; Bobakulov K; Xin XL; Elmuradov B; Shakhidoyatov K; Aisa HA
Eur J Med Chem; 2014 Sep; 84():739-45. PubMed ID: 25064350
[TBL] [Abstract][Full Text] [Related]
18. Role of the BCA2 ubiquitin E3 ligase in hormone responsive breast cancer.
Burger AM; Kona F; Amemiya Y; Gao Y; Bacopulos S; Seth AK
Open Cancer J; 2010; 3(1):116-123. PubMed ID: 21179390
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
Croker AK; Allan AL
Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590
[TBL] [Abstract][Full Text] [Related]
20. Effects of the SUMO Ligase BCA2 on Metabolic Activity, Cell Proliferation, Cell Migration, Cell Cycle, and the Regulation of NF-κB and IRF1 in Different Breast Epithelial Cellular Contexts.
Shi Y; Castro-Gonzalez S; Chen Y; Serra-Moreno R
Front Cell Dev Biol; 2021; 9():711481. PubMed ID: 34589482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
